SENO ретатрутид лиофилизированный порошок оптовая цена

Описание

Multi-Receptor Agonist Пептид for Metabolic & Endocrine Research

Retatrutide is a next-generation synthetic research peptide investigated for its triple receptor agonist activity involving GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Its multi-pathway mechanism has made it an important compound in advanced metabolic, obesity, endocrine, and receptor-signaling research models.

SENO supplies high-purity Retatrutide lyophilized powder in multiple research specifications ranging from 5mg to 100mg per vial set. Each batch is manufactured using automated solid-phase peptide synthesis (SPPS), purified by preparative HPLC, and verified using analytical mass spectrometry.

Available specifications:

  • RT5 — 5mg × 10 vials
  • RT10 — 10mg × 10 vials
  • RT15 — 15mg × 10 vials
  • RT20 — 20mg × 10 vials
  • RT30 — 30mg × 10 vials
  • RT40 — 40mg × 10 vials
  • RT50 — 50mg × 10 vials
  • RT60 — 60mg × 10 vials
  • RT100 — 100mg × 10 vials

This peptide is supplied exclusively for laboratory research applications.


What Is Retatrutide?

Retatrutide is a synthetic multi-receptor agonist peptide designed to simultaneously target:

  • GLP-1 receptors
  • GIP receptors
  • glucagon receptors

Its molecular structure was developed to investigate how combined receptor activation influences:

  • metabolic regulation
  • energy expenditure
  • glucose metabolism
  • hormonal signaling
  • receptor crosstalk mechanisms

Unlike single-pathway peptide compounds, Retatrutide is studied for its ability to activate multiple metabolic signaling systems simultaneously, making it highly relevant in obesity, endocrine, and receptor pharmacology research.

The peptide is typically supplied as a white lyophilized powder to preserve structural stability during storage and transport.


Исследовательские приложения

Retatrutide is widely used in advanced laboratory investigations involving:

  • GLP-1 receptor pathway studies
  • GIP receptor signaling research
  • glucagon receptor modulation analysis
  • metabolic pathway investigations
  • obesity and energy balance models
  • endocrine system research
  • receptor-binding affinity studies
  • peptide pharmacodynamics analysis
  • multi-hormonal signaling experiments
  • preclinical metabolic research

Its triple agonist profile makes Retatrutide particularly valuable in studies exploring synergistic receptor interactions and integrated metabolic regulation.


Молекулярная формула

C221H342N46O68C_{221}H_{342}N_{46}O_{68}


Молекулярная масса

4837.4 g/mol4837.4\ g/mol


Номер CAS

ПараметрПодробности
Название продуктаРетатрутид
Номер CAS2381089-83-2
Молекулярный типSynthetic peptide
ФормаЛиофилизированный порошок
Чистота≥98% (HPLC verified)

Технические характеристики продукта

Код товараТехнические характеристикиФорма
RT55mg × 10 vialsЛиофилизированный порошок
RT1010mg × 10 vialsЛиофилизированный порошок
RT1515mg × 10 vialsЛиофилизированный порошок
RT2020mg × 10 vialsЛиофилизированный порошок
RT3030mg × 10 vialsЛиофилизированный порошок
RT4040mg × 10 vialsЛиофилизированный порошок
RT5050mg × 10 vialsЛиофилизированный порошок
RT6060mg × 10 vialsЛиофилизированный порошок
RT100100mg × 10 vialsЛиофилизированный порошок

Механизм действия

Retatrutide is investigated as a triple receptor agonist capable of interacting with:

  • GLP-1 receptors
  • GIP receptors
  • glucagon receptors

This multi-target mechanism is studied for its effects on metabolic signaling networks and energy homeostasis.

Primary research interests include:

GLP-1 Receptor Activity

Associated with investigations into:

  • glucose regulation
  • insulin signaling
  • appetite-related pathways

GIP Receptor Activity

Studied in relation to:

  • incretin biology
  • metabolic modulation
  • hormonal signaling coordination

Glucagon Receptor Activity

Researched for potential influence on:

  • energy expenditure
  • lipid metabolism
  • hepatic metabolic pathways

The simultaneous activation of these receptor systems makes Retatrutide distinct from traditional single-pathway metabolic peptides.


Растворимость

Retatrutide is generally soluble in:

  • стерильная вода
  • бактериостатическая вода
  • фосфатно-буферный солевой раствор (PBS)
  • selected research buffers

Solubility characteristics may vary depending on:

  • preparation concentration
  • pH conditions
  • temperature
  • experimental protocol

Researchers commonly prepare aliquots to reduce repeated freeze-thaw exposure after reconstitution.


Рекомендации по хранению

Для оптимальной стабильности пептидов:

  • Store lyophilized powder at -20°C
  • Protect from direct light and moisture
  • Избегайте резких перепадов температуры
  • Use sterile handling procedures during preparation

После восстановления:

  • Store at 2–8°C for short-term use
  • Минимизация циклов замораживания-размораживания
  • Use freshly prepared solutions whenever possible

Информация о стабильности

Retatrutide is supplied in lyophilized form to improve long-term structural stability and reduce degradation risk during transport and storage.

Peptide stability may be affected by:

  • окисление
  • гидролиз
  • температурное воздействие
  • pH conditions
  • многократные циклы замораживания-размораживания
  • микробное загрязнение

Lyophilization helps maintain peptide integrity by reducing moisture exposure during storage.


Научные исследования и научный интерес

Retatrutide has become a major subject of interest in metabolic and endocrine research due to its simultaneous receptor-targeting design.

Current areas of laboratory investigation include:

  • integrated hormonal signaling
  • metabolic regulation models
  • obesity-related pathway research
  • glucose homeostasis studies
  • фармакология рецепторов
  • peptide-receptor interaction analysis
  • energy expenditure mechanisms

Its multi-receptor mechanism has expanded scientific interest in combination pathway modulation approaches within peptide research.


Производство и обеспечение качества

SENO manufactures Retatrutide using automated solid-phase peptide synthesis (SPPS) platforms under controlled laboratory conditions.

Производственный процесс включает в себя:

  • pharmaceutical-grade amino acid sourcing
  • automated peptide chain elongation
  • controlled deprotection and coupling cycles
  • препаративная ВЭЖХ-очистка
  • analytical mass spectrometry confirmation
  • процедуры стерильной лиофилизации

Each production batch undergoes analytical verification to support:

  • чистота консистенция
  • peptide identity confirmation
  • structural integrity
  • воспроизводимость партии

This controlled manufacturing process helps ensure reliable performance in sensitive laboratory experiments.


COA (сертификат анализа)

Аналитическая документация может включать:

  • номер партии
  • peptide identity
  • HPLC purity analysis
  • масс-спектрометрическая верификация
  • проверка внешнего вида
  • рекомендации по хранению
  • дата изготовления

COA documentation supports laboratory traceability and internal research quality-control procedures.


ВЭЖХ и масс-спектрометрическая верификация

Each batch undergoes analytical testing using:

  • Высокоэффективная жидкостная хроматография (ВЭЖХ)
  • Масс-спектрометрия (МС)

These analytical methods help verify:

  • чистота пептидов
  • молекулярная идентичность
  • batch consistency
  • impurity profile assessment

HPLC chromatograms and MS data may be available for research documentation purposes.


Руководство по восстановлению

Рекомендуемая лабораторная процедура

  1. Перед вскрытием дайте флакону нагреться до комнатной температуры.
  2. Prepare sterile water or appropriate research buffer.
  3. Slowly inject solvent along the vial wall.
  4. Avoid direct high-pressure impact on the lyophilized powder.
  5. Слегка взбейте до полного растворения.
  6. Do not shake vigorously.
  7. Aliquot prepared solution when possible.
  8. Store prepared solutions under recommended conditions.

Reconstitution concentrations should be optimized according to individual research protocols.


Меры предосторожности при обращении

  • Только для лабораторных исследований
  • Не предназначен для применения у людей или в ветеринарии
  • Use appropriate laboratory PPE
  • Handle using sterile technique
  • Avoid contamination during preparation
  • Dispose of materials according to institutional regulations

Информация о доставке

  • Worldwide shipping via FedEx or equivalent courier
  • Supplied as lyophilized powder for improved transport stability
  • Secure protective packaging
  • Designed for international laboratory shipping workflows

Часто задаваемые вопросы (FAQ)

What is Retatrutide used for in research?

Retatrutide is commonly studied in metabolic, endocrine, receptor-signaling, and obesity-related laboratory investigations due to its triple receptor agonist profile.


Why is Retatrutide considered a triple agonist?

The peptide is designed to interact with GLP-1, GIP, and glucagon receptors simultaneously, allowing researchers to investigate integrated metabolic signaling pathways.


How is Retatrutide supplied?

SENO supplies Retatrutide as a white lyophilized powder in multiple vial specifications ranging from RT5 to RT100.


Why is the peptide lyophilized?

Lyophilization helps improve peptide stability during storage and international shipping by reducing moisture-related degradation.


How should Retatrutide be stored?

Lyophilized peptide should generally be stored at -20°C. Reconstituted solutions are typically stored at 2–8°C and used within a short period.


Is this product intended for medical or therapeutic use?

No. Retatrutide supplied by SENO is strictly intended for laboratory research applications only and is not approved for human or veterinary use.